Login to Your Account

BIO 2010

As Financial Sources Thin Out, Pharma Pushes Back on Deals

By Nuala Moran

Wednesday, May 12, 2010
CHICAGO - Pharma deals have become the last port in a storm as venture capital, initial public offerings (IPO) and funding from other sources have dried up. But while more relationships are being consummated, pharma is pushing the risk back onto biotech partners, with smaller up-front payments and many milestones staged along the long route to approval. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription